Fol. Biol. 2018, 64, 173-181
https://doi.org/10.14712/fb2018064050173
TSG-6 Induces Apoptosis of Human Hypertrophic Scar Fibroblasts via Activation of the Fas/FasL Signalling Pathway
References
1. , B. B., Singh, S., LaPushin, R., Totpal, K. (1995) Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364, 5-8.
<https://doi.org/10.1016/0014-5793(95)00339-B>
2. , B. C., Alappat, E. C., Peter, M. E. (2003) The CD95 type I/type II model. Semin. Immunol. 15, 185-193.
<https://doi.org/10.1016/S1044-5323(03)00031-9>
3. , J., Roberge, C. J., Bergeron, D., Lopez-Valle, C. A., Roy, M., V. J. Moulin, V. J. (2005) Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J. Pathol. 206, 1-8.
<https://doi.org/10.1002/path.1737>
4. , L., Wang, Z., Li, S., Zhao, G., Tian, M., Sun, Z. (2012) SFRP2 and slug contribute to cellular resistance to apoptosis in hypertrophic scars. PLoS One 7, e50229.
<https://doi.org/10.1371/journal.pone.0050229>
5. , H., Lee, R. H., Bazhanov, Y. Oh, J. Y. Prockop, D. J. (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood 118, 330-338.
<https://doi.org/10.1182/blood-2010-12-327353>
6. , A., Redard, M., Darby, I., Gabbiani, G. (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56-66.
7. , R. A., Spencer, D. M., Choate, K. A., Duh, H. J., Schreiber, S. L., Crabtree, G. R., Khavari, P. A. (1997) Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J. Invest. Dermatol. 108, 215-219.
<https://doi.org/10.1111/1523-1747.ep12334273>
8. , M.,Muragaki, M. Y., Ooshima, A. (2005) Keloidderived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br. J. Dermatol. 153, 295-300.
<https://doi.org/10.1111/j.1365-2133.2005.06698.x>
9. , G. G., Korting, H. C., Pavicic, T., Ruzicka, T., Jeschke, M. G. (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol. Med. 17, 113-125.
<https://doi.org/10.2119/molmed.2009.00153>
10. , Z., T. Mak, T. W. (2010) Type I and type II pathways of Fas-mediated apoptosis are differentially controlled by XIAP. J. Mol. Cell Biol. 2, 63-64.
<https://doi.org/10.1093/jmcb/mjp034>
11. , A., Korn, H. J. (1998) Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J. Cell. Physiol. 175, 19-29.
<https://doi.org/10.1002/(SICI)1097-4652(199804)175:1<19::AID-JCP3>3.0.CO;2-F>
12. , L., Lee, T. H., Hsu, H., Vilcek, J., Chen-Kiang, S. (1994) NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor α and interleukin-1. Mol. Cell. Biol. 14, 6561-6569.
13. , T. H., Lee, G. W., Ziff, E. B., Vilcek, J. (1990) Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell. Biol. 10, 1982-1988.
14. , T. H., Wisniewski, H. G., Vilcek, J. (1992) A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell. Biol. 116, 545-557.
<https://doi.org/10.1083/jcb.116.2.545>
15. , T. H., Klampfer, L., Shows, T. B., Vilcek, J. (1993) Transcriptional regulation of TSG6, a tumor necrosis factorand interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein. J. Biol. Chem. 268, 6154-6160.
<https://doi.org/10.1016/S0021-9258(18)53232-4>
16. , P., Daburon, S., Moreau, P., Ichas, F., de Giorgi, F., Moreau, J. F., Taupin, J. L. (2005) Amplification of Fasmediated apoptosis in type II cells via microdomain recruitment. Mol. Cell. Biol. 25, 6811-6820.
<https://doi.org/10.1128/MCB.25.15.6811-6820.2005>
17. , K., Manji,A., Gallant-Behm, C., Wiebe, C., Hart, D. A., Larjava, H., Hakkinen, L. (2009) Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model. J. Dermatol. Sci. 56, 168-180.
<https://doi.org/10.1016/j.jdermsci.2009.09.005>
18. , D. V., Le, A., Berg, S., Huang, G., Zhuang, W., Bertolami, C. N. (1998) Effect of TGF-β 1 on PDGF receptors expression in human scar fibroblasts. Front. Biosci. 3, a16-22.
19. , C. M., Day, A. J. (2003) TSG-6: a multifunctional protein associated with inflammation. J. Cell Sci. 116(Pt 10), 1863-1873.
<https://doi.org/10.1242/jcs.00407>
20. , S., Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
<https://doi.org/10.1126/science.7533326>
21. , H., Miyauchi, S., Miki , Y. (1995) Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm. Venereol. 75, 102-104.
<https://doi.org/10.2340/0001555575102104>
22. , M., Maeda, K., Sugiyama, S. (1994) Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch. Dermatol. Res. 286, 396-407.
<https://doi.org/10.1007/BF00371800>
23. , K., Ferrari, D., Los, M., Wesselborg, S., Peter, M. E. (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459.
<https://doi.org/10.1046/j.1432-1327.1998.2540439.x>
24. , M. E., Shelton, S. N., Robertson, J. D. (2009) Caspase- 9 activation by the apoptosome is not required for Fas-mediated apoptosis in type II Jurkat cells. J. Biol. Chem. 284, 33447-33455.
<https://doi.org/10.1074/jbc.M109.032359>
25. , K. T., McGrouther, D. A., Day, A. J., Milner, C. M., A. Bayat, A. (2011) Characterization of hyaluronan and TSG- 6 in skin scarring: differential distribution in keloid scars, normal scars and unscarred skin. J. Eur. Acad. Dermatol. Venereol. 25, 317-327.
<https://doi.org/10.1111/j.1468-3083.2010.03792.x>
26. , C. (2009) Tissue engineering in wound repair: the three “R”s - repair, replace, regenerate. Vet. Surg. 38, 905-913.
<https://doi.org/10.1111/j.1532-950X.2009.00585.x>
27. , H., Chen, Z., Li, X. J., Ma, L., Tang, Y. L. (2015) Antiinflammatory cytokine TSG-6 inhibits hypertrophic scar formation in a rabbit ear model. Eur. J. Pharmacol. 751, 42-49.
<https://doi.org/10.1016/j.ejphar.2015.01.040>
28. , J., Dodd, C., Shankowsky, H. A., Scott, P. G., Tredget, E. E. (2008) Deep dermal fibroblasts contribute to hypertrophic scarring. Lab. Invest. 88, 1278-1290.
<https://doi.org/10.1038/labinvest.2008.101>
29. , H. G., Vilcek, J. (1997) TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev. 8, 143-156.
<https://doi.org/10.1016/S1359-6101(97)00008-7>
